Source: NS Medical Devices

bioLytical: bioLytical Laboratories launches INSTI HCV antibody test in Australia

bioLytical Laboratories has announced the commercial launch of its INSTI HCV Antibody Test in the Australian market.

Read full article »
bioLytical's Competitors | bioLytical's News | bioLytical's Financials
Stay up-to-date with the latest news on bioLytical
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Robert Mackie's photo - Chairman & CEO of bioLytical

Chairman & CEO

Robert Mackie

CEO Approval Rating

89/100

Read more
Stay up-to-date with the latest news on bioLytical